SIM. IP Practice

Offices

Canada
1. Toronto ON
  
  330 University Avenue, 6th Floor, Toronto ON M5G 1R7, Canada T 1 416 595 1155 F 1 416 595 1163 W www.simip.com info@simip.com

The Federal Court warns against using sound prediction as a “crushing hammer”
Canada - March 25 2013
The Federal Court has arguably pleased the patentee side of the fence in its recent decision finding that Novartis’ tumour drug patent had the
Is the Patented Medicines Prices Review Board (“PMPRB”) extending itself beyond actual “patentees” and “patented medicines”?
Canada - September 14 2012
The blurring of “brand” and “generic” has arguably grown over the past few years as companies develop strategies to take advantage of the best of both worlds
FCA finds possible estoppel once again Apotex may be bound by earlier foreign and Canadian findings
Canada - March 28 2012
The Federal Court of Appeal (“FCA”) recently agreed that AstraZeneca is permitted, as part of its claim for patent infringement, to plead that Apotex is bound by prior decisions finding infringement
Pfizer kicked when down: Federal Court provides added certainty that VIAGRA patent is now invalid and void
Canada - November 22 2012
The Federal Court has followed the lead of the Supreme Court of Canada (“SCC”) and declared the VIAGRA patent “invalid” and “void”
Eli Lilly olanzapine appeal dismissed from bench
Canada - September 17 2012
From the bench, the Federal Court of Appeal (“FCA”) dismissed Eli Lilly’s appeal from the decision of Justice O’Reilly on November 10, 2011

See more articles

The Federal Court warns against using sound prediction as a “crushing hammer”
Canada - March 25 2013
The Federal Court has arguably pleased the patentee side of the fence in its recent decision finding that Novartis’ tumour drug patent had the
“Computer problems” solved by Canadian Patent Office?
Canada - March 21 2013
On March 8, 2013, the Canadian Intellectual Property Office (CIPO) issued a new Practice Notice (PN2013-03) to all Canadian Patent Examiners with
Bill C-56 aims to introduce new provisions in the Trade-marks Act
Canada - March 15 2013
On March 1, 2013, the Canadian government introduced Bill C-56, titled the Combating Counterfeit Products Act (the "Bill"), which proposes to
A Canadian perspective on purposive construction: solving a problem with an interesting solution
Canada - March 11 2013
On March 8, 2013, the Canadian Intellectual Property Office (CIPO) issued a new Practice Notice (PN2013-02) to all Canadian Patent Examiners
Federal Court of Appeal finds 50 year old drug not an innovative drug
Canada - March 6 2013
The Federal Court of Appeal (“FCA”) in a split decision denied Celgene’s request to have its “new” thalidomide drug product designated as an

See more articles